For Admin
A Leading Company in Nasal Drug Delivery
SNBL’s nasal drug delivery platform is a proprietary system consisting of powder carrier technology and delivery device technology.
3D Nasal Cast Model
June 26, 2023
SNBL Announces Results of Collaboration Research with Hamamatsu University School of Medicine Using SNBL’s Nose-to-Brain Delivery Technology
May 19, 2023
Satsuma Pharmaceuticals Announces FDA Acceptance of NDA for STS101, a Novel and Investigational DHE Nasal Powder Product for the Acute Treatment of Migraine
April 17, 2023
SNBL Enters into Definitive Agreement to Acquire Satsuma Pharmaceuticals, Inc.
2024|2023|2022|2021|2020|2019|2018|2016|2015|2014|2013|2012〜